Thor Medical ASA: Mechanical Completion Achieved at Herøya Facility, AlphaOne

“This is a major achievement for Thor Medical and a testament to the strong execution capabilities of our team and partners,” said Jasper Kurth, Chief Executive Officer of Thor Medical ASA.

Mechanical completion confirms that all major construction and installation activities have been finalized in accordance with project specifications. The facility has now entered the commissioning phase, which partly commenced already in March. During commissioning, systems and equipment are being tested, verified, and prepared for operational start-up. Commissioning activities are expected to continue toward production start in the third quarter this year.

“Reaching Mechanical Completion, alongside the successful start of commissioning, keeps us firmly on track toward commencing production in the third quarter and delivering on our strategy to become a leading supplier of alpha-emitting radioisotopes for cancer treatment,” Kurth added.

The AlphaOne facility at Herøya Industrial Park will play a central role in Thor Medical’s mission to address the growing global demand for radiopharmaceuticals.